Showing 1471-1480 of 4166 results for "".
EMPOWER - Optimizing Contact Lens Wear
https://modernod.com/podcasts/the-mod-pod/empower-optimizing-contact-lens-wear/36884/In this second episode of the EMPOWER series, Ashley Tucker, OD, FAAO, FSLS, Dipl ABO, and Jessica O. Yu, OD, FAAO, FSLS, sit down with Jacob Lang, OD, FAAO, to discuss how to tackle the most common causes of contact lens dropout. With a focus on practical, evidence-based strategies, this conversatiElevating Your Orthokeratology Fitting Using Topography and Biometry for Myopia Control
https://modernod.com/mod-issues/supplements-inserts/elevating-your-orthokeratology-fitting-using-topography-and-biometry-for-myopia-control/38572/The first part of a three-part series exploring myopia management.Ded Treatments on the Horizon: Tolerability and Efficacy of the Melanocortin Agonist Pl9643
https://modernod.com/mod-issues/supplements-inserts/ded-treatments-on-the-horizon-tolerability-and-efficacy-of-the-melanocortin-agonist-pl9643/38352/COLLAB CORNER - Managing Patient Expectations for Refractive Procedures
https://modernod.com/podcasts/collaborative-corner-the-podcast/collab-corner-managing-patient-expectations-for-refractive-procedures/36887/Marc R. Bloomenstein, OD, FAAO, invites Justin Schweitzer, OD, FAAO, to discuss collaborative care of patients undergoing refractive surgery. Dr. Schweitzer shares his decision tree for recommending specific refractive procedures in different patient cases, including LASIK, implantable collamer lensA Case of LACRIFILL® Canalicular Gel Treatment in a Patient With Demodex Blepharitis Infestation and Uncontrollable DED
https://modernod.com/mod-issues/supplements-inserts/a-case-of-lacrifillsupsup-canalicular-gel-treatment-in-a-patient-with-demodex-blepharitis-infestation-and-uncontrollable-ded/38977/Autoimmune Rheumatic Disease
https://modernod.com/mod-issues/2026-mar-apr/autoimmune-rheumatic-disease/56859/Learn these clues to see whether you may be dealing with more than dry eye disease.Alcon Acquires Staar for $1.5 Billion
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-acquires-staar-for-15-billion/37096/Alcon makes a major acquisition to expand its refractive portfolio; the CEO of Lenz Therapeutics joins us to discuss the FDA approval of a new presbyopia drop; and the optical industry braces for major changes as new reciprocal tariffs are set to begin this week. Learn more about your ad choices.A Novel Therapy Can Increase Patient Satisfaction in Patients With Dry Eye
https://modernod.com/mod-issues/supplements-inserts/a-novel-therapy-can-increase-patient-satisfaction-in-patients-with-dry-eye/38973/The 2025 patient experience survey results are positive.The One Big, Beautiful Bill Act, Explained
https://modernod.com/topics/business/the-one-big-beautiful-bill-act-explained/39831/Practice owners: Get ready to make the most out of this new tax legislation.Glaucoma Pipeline 2026 PDF
https://cdn.modernod.com/uploads/mod/glaucoma-pipeline-2026/1125GT_CRST_MOD%2520Glaucoma%2520Pipeline%2520Poster.pdf